LeMaitre Vascular Stock Price and Value Analysis

Should you buy LeMaitre Vascular stock? (NasdaqGM:LMAT). Let's see how it does in our automated value investing analysis system.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold LeMaitre Vascular to reach your target.

Target type
AdvantagesDisadvantages
None.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company is less known than others.
  • This company is making money at a modest rate.
  • This company has a low dividend yield.

Inside the LMAT Numbers

LMAT Price
(LeMaitre Vascular stock price per share)
$95.59
[?] LMAT Fair Price
(based on intrinsic value)
$7.28
[?] LMAT Safety Price (based on a variable margin of safety) $4.37
[?] PE Ratio versus Sector 73% higher than other Healthcare stocks
[?] PE Ratio versus Industry 63% higher than other Medical Devices stocks
[?] Free Cash Flow Jitter 59%
[?] Dividend Yield 1% (tax impact)
Shares Shorted 1,479,856

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 1,479,856 shares shorted. With 21,269,696 shares available for purchase and an average trading volume over the past 10 trading days of 265,930, it would take at least 5.565 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Is LeMaitre Vascular Stock on Sale?

We believe that LeMaitre Vascular may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

LeMaitre Vascular looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Advertisement supports free stock analysis content.

Should You Buy LMAT Stock?

Does LeMaitre Vascular have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

We don't yet have enough financial history for LeMaitre Vascular to produce a full worked example. Check back as more data becomes available, or see the current price and research links below.